A case of angiolymphoid hyperplasia with eosinophilia treated with intralesional interferon alfa-2a.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M Rinker.
Explore the source record for details and available documents.
This paper describes a thermoacoustic sensor developed for measurements of the acoustic power and calibration of ultrasonic transducers in the medical imaging and nondestructive testing frequency range. It is shown that the equilibrium temperature produced by ultrasound absorption in an absorbing material and detected by a copper-constantan thermocouple is proportional to the square of the current applied to the acoustic source. It is also demonstrated that the simultaneous measurement of this current and the corresponding equilibrium temperature at a given frequency allow the transmitting current sensitivity of the acoustic source to be calculated. The sensor thus provides a useful and low-cost alternative to the expensive calibration methods such as those based on the reciprocity technique, the planar scanning technique and the radiation force balance. The principles of the sensor's operation are outlined and its construction and characteristics are described. Experimental data in the frequency range of 1-8 MHz are presented and the advantages and disadvantages of the sensor are discussed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
BACKGROUND: Transplantation of hematopoietic stem cells (HSC) is an effective treatment for a number of patients with life-threatening hematologic diseases. HSC donors can be found in the family of the patient or in registries of unrelated donors. In the present study, the search procedure within the last two years for an allogeneic HSC donor at the University of Düsseldorf is analyzed. PATIENTS AND METHODS: During 1997 and 1998, an early search for a related HSC donor in the family was performed for 70 high risk pediatric patients. During the same period, the search for an unrelated HSC donor for 116 adult and pediatric patients was performed. Low resolution HLA-A and -B typing was performed by serology in combination with DNA-typing. High resolution typing of HLA-A, -B and -C was carried out by DNA-sequencing. Low resolution HLA-DRB- und HLA-DQB1-typing was done solely by DNA-typing and high resolution typing of these genes was performed by DNA-sequencing. MAIN RESULTS: For 51 of 70 high risk pediatric patients (73%), no family donor could be defined, 16 of 70 patients (23%) had a genotypically identical sibling and for three of 70 patients (4%) an HLA-acceptable donor in the extended family could be identified. The search for an unrelated HSC donor was successful in 74% of the adult and pediatric patients lacking such a family donor. Most noteworthy, nearly all of the HLA-acceptable donors were identified from that group of donors in the registries, which were not only HLA-A and HLA-B, but also HLA-DR pretyped. CONCLUSION: These data show, that a growing number of pediatric patients with high risk leukemia need an unrelated HSC donor and that HLA-ABDR-pretyped registries present the optimal prerequisite to identify an HSC donor for most of the patients. In addition, 25% of the patients with no family or unrelated HSC donor require HSC transplants from alternative donors like unrelated Cord Blood (CB) from high quality cord blood banks.
Explore the source record for details and available documents.